His primary areas of study are Internal medicine, Endocrinology, Appetite, Obesity and Insulin. The Internal medicine study combines topics in areas such as Diabetes mellitus, Type 2 diabetes and Crossover study. His Type 2 diabetes study frequently involves adjacent topics like Surgery.
His study explores the link between Surgery and topics such as Macrovascular disease that cross with problems in Insulin detemir, Insulin lispro, Insulin aspart, Chlorpropamide and Sudden death. His biological study deals with issues like Meal, which deal with fields such as Caloric theory, Protein intake and Animal science. His biological study spans a wide range of topics, including Body mass index and Hormone.
Gary Frost mostly deals with Internal medicine, Endocrinology, Appetite, Obesity and Diabetes mellitus. Gary Frost regularly links together related areas like Type 2 diabetes in his Internal medicine studies. Gary Frost works mostly in the field of Endocrinology, limiting it down to topics relating to Propionate and, in certain cases, Inulin, as a part of the same area of interest.
His Appetite research includes elements of Meal, Crossover study, Hormone, Ingestion and Anorectic. His research investigates the link between Obesity and topics such as Body mass index that cross with problems in Anthropometry. The study incorporates disciplines such as Physical therapy and Surgery in addition to Weight loss.
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Type 2 diabetes, Environmental health and Diabetes mellitus. His Internal medicine research incorporates themes from Gastroenterology and Gut flora. His Endocrinology research is multidisciplinary, relying on both Chemokine, Propionate and Monocyte.
Gary Frost has included themes like Type 2 Diabetes Mellitus, Obesity, Omics and Cohort in his Type 2 diabetes study. His research investigates the connection with Environmental health and areas like Dietary assessment which intersect with concerns in Food intake and Malnutrition. His research in Diabetes mellitus tackles topics such as Weight loss which are related to areas like Fructosamine.
Internal medicine, Gut flora, Propionate, Type 2 diabetes and Endocrinology are his primary areas of study. Gary Frost studies Obesity, a branch of Internal medicine. His Gut flora study combines topics in areas such as Fermentation, Digestion and Glucagon-like peptide-1.
Gary Frost interconnects Signal transduction, G protein-coupled receptor, Inulin, Insulin resistance and Internalization in the investigation of issues within Propionate. His study in Type 2 diabetes is interdisciplinary in nature, drawing from both Omics, Cohort and Receiver operating characteristic. His Energy expenditure and Weight gain study, which is part of a larger body of work in Endocrinology, is frequently linked to Increased lipid, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
R C Turner;R R Holman;C A Cull;I M Stratton.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
M R Stearne;S L Palmer;M S Hammersley;S L Franklin.
Ghrelin enhances appetite and increases food intake in humans.
A. M. Wren;L. J. Seal;M. A. Cohen;A. E. Brynes.
The Journal of Clinical Endocrinology and Metabolism (2001)
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
M R Stearne;S L Palmer;M S Hammersley;S L Franklin.
Inhibition of food intake in obese subjects by peptide YY3-36.
Rachel L Batterham;Mark A Cohen;Sandra M Ellis;Carel W Le Roux.
The New England Journal of Medicine (2003)
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.
Nicola M. Neary;Caroline J. Small;Alison M. Wren;Jennifer L. Lee.
The Journal of Clinical Endocrinology and Metabolism (2004)
The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism
Gary Frost;Michelle L. Sleeth;Meliz Sahuri-Arisoylu;Blanca Lizarbe.
Nature Communications (2014)
Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults
Edward S. Chambers;Alexander Viardot;Arianna Psichas;Douglas J. Morrison.
Inflammatory disease processes and interactions with nutrition
P. C. Calder;R. Albers;J.-M. Antoine;S. Blum.
British Journal of Nutrition (2009)
Pancreatic polypeptide reduces appetite and food intake in humans.
R. L. Batterham;C. W. Le Roux;M. A. Cohen;A. J. Park.
The Journal of Clinical Endocrinology and Metabolism (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: